speb/financial-data huggingface dataset:
Financial ratios for CCA.AX — annual report dated 2023-06-30
Total revenue: 5724153.642384106
Gross profit: 5724153.642384106
Operating income: -1724118.5430463576
Net income: -1932733.1125827814
Capital expenditures: 12871.523178807947
Depreciation & amortization: 850288.0794701987
Net tangible assets: 1387208.609271523
Owner earnings: -1095316.5562913907
Return on net tangible assets (%): -78.95831592817059
Buffett classification: The Gruesome
Stock price: 0.026490066225165563
Shares outstanding: 690453020
Book value: 5587905.298013244
P/B ratio: 3.273166821862308
Market cap (USD): 18290146.225165565
Debt to equity: 0.016148050122918034
Current ratio: 1.4431686940674053
Quick ratio: 1.4431686940674053
Interest coverage ratio: -33.18444164021771
COGS to revenue (%): 0
SG&A to revenue (%): 67.59392521893979
Free cash flow (dilution-adjusted): -1711696.0264900662
Buyback yield (%): 1.828502393978956
Retained earnings: -31041935.09933775
Receivables turnover: 4.075327439369672
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.301701525178075
FCF margin (%): -29.903041277856858
Revenue growth (%): 1.7606229088642262
Rule of 40 score: -28.14241836899263
Financial ratios for CD3.AX — annual report dated 2022-03-31
Total revenue: -241846
Net income: 58696010
Capital expenditures: 0
Net tangible assets: 166307965
Owner earnings: 58696010
Return on net tangible assets (%): 35.293565163881354
Buffett classification: The Gruesome
Stock price: 0.48872180451127817
P/E ratio: 0.5997317262024495
Shares outstanding: 72028420
Book value: 166307965
P/B ratio: 0.21166670759573203
Market cap (USD): 35201859.39849624
Debt to equity: 0
Effective tax rate (%): 6.879500974730123
Free cash flow (dilution-adjusted): -942794
Buyback yield (%): 0
Retained earnings: 56635349
Receivables turnover: -12.422106939236736
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CD3.AX — annual report dated 2023-03-31
Total revenue: 233026.9
Net income: 29317390
Capital expenditures: 0
Net tangible assets: 155217412
Owner earnings: 29317390
Return on net tangible assets (%): 18.88795182334312
Buffett classification: The Gruesome
Stock price: 0.5637583892617449
P/E ratio: 1.3850696136412024
Shares outstanding: 72028420
Book value: 155217412
P/B ratio: 0.261611281344315
Market cap (USD): 40606626.04026845
Debt to equity: 0
Effective tax rate (%): 2.671461376020057
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -1336307
Buyback yield (%): 0
Retained earnings: 45544796
Receivables turnover: 7.991320301783264
Capitalized R&D asset: 0
FCF margin (%): -573.4561117192908
Rule of 40 score: -573.4561117192908
Financial ratios for CD3.AX — annual report dated 2024-03-31
Total revenue: 615698
Net income: 2244818
Capital expenditures: 0
Net tangible assets: 130811714
Owner earnings: 2244818
Return on net tangible assets (%): 1.71606802736336
Buffett classification: The Gruesome
Stock price: 0.7320261437908497
P/E ratio: 23.488178790417628
Shares outstanding: 72028420
Book value: 130811714
P/B ratio: 0.4030731264322988
Market cap (USD): 52726686.53594772
Debt to equity: 0
Effective tax rate (%): -16.26512669782859
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -1397903
Buyback yield (%): 0
Retained earnings: 21139098
Receivables turnover: 23.998207047084502
Capitalized R&D asset: 0
FCF margin (%): -227.0436155387869
Revenue growth (%): 164.2175645815998
Rule of 40 score: -62.82605095718711
Financial ratios for CD3.AX — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 134961359
Buffett classification: The Gruesome
Stock price: 0.660377358490566
Shares outstanding: 72028420
Book value: 134961359
P/B ratio: 0.3524411586271079
Market cap (USD): 47565937.73584905
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 25288743
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CD3.AX — annual report dated 2025-03-31
Total revenue: -171161
Net income: 18555329
Capital expenditures: 0
Net tangible assets: 134961359
Owner earnings: 18555329
Return on net tangible assets (%): 13.74862341153515
Buffett classification: The Gruesome
Stock price: 0.660377358490566
P/E ratio: 2.5634650690294447
Shares outstanding: 72028420
Book value: 134961359
P/B ratio: 0.3524411586271079
Market cap (USD): 47565937.73584905
Debt to equity: 0
Effective tax rate (%): -13.674363856028258
Free cash flow (dilution-adjusted): -848219
Buyback yield (%): 0
Retained earnings: 25288743
Receivables turnover: -8.703396725312723
Capitalized R&D asset: 0
Revenue growth (%): -127.7995056017723
Rule of 40 score: -127.7995056017723
Financial ratios for CIP.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.1654135338345863
Shares outstanding: 624388000
Market cap (USD): 1352058225.5639098
Buyback yield (%): 0.5343009652829829
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIP.AX — annual report dated 2022-06-30
Total revenue: 140362068.96551725
Gross profit: 124864137.93103449
Operating income: 91873793.10344827
Net income: 253434482.7586207
Capital expenditures: 0
Net tangible assets: 1854720689.6551726
Owner earnings: 253434482.7586207
Return on net tangible assets (%): 13.664293722077309
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.572413793103448
P/E ratio: 3.8739649504734945
Shares outstanding: 624388000
Book value: 1854720689.6551728
P/B ratio: 0.5293499495230249
Market cap (USD): 981796303.4482757
Debt to equity: 0.5105440172235246
Current ratio: 1.0955296012887636
Quick ratio: 1.0955296012887636
Effective tax rate (%): 0
Interest coverage ratio: 4.950648481920547
COGS to revenue (%): 11.041395405969782
Free cash flow (dilution-adjusted): 77192413.79310346
Buyback yield (%): 0.4653679690170159
Retained earnings: 585418620.6896552
Receivables turnover: 13.723870532703978
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2702989192206675
FCF margin (%): 54.995209433730494
Rule of 40 score: 54.995209433730494
Financial ratios for CIP.AX — annual report dated 2023-06-30
Total revenue: 147071523.17880794
Gross profit: 131037748.34437086
Operating income: 95150993.37748344
Net income: -50733774.83443709
Capital expenditures: 0
Net tangible assets: 1663012582.781457
Owner earnings: -50733774.83443709
Return on net tangible assets (%): -3.0507150312466527
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.7549668874172184
Shares outstanding: 624388000
Book value: 1663012582.781457
P/B ratio: 0.65891279251052
Market cap (USD): 1095780264.9006622
Debt to equity: 0.5136517187948625
Current ratio: 1.4570536630486624
Quick ratio: 1.4570536630486624
Interest coverage ratio: 3.270314562753221
COGS to revenue (%): 10.902025414494005
Free cash flow (dilution-adjusted): 64637748.34437086
Buyback yield (%): 0
Retained earnings: 444146357.615894
Receivables turnover: 13.569473298301357
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.74395650612701
FCF margin (%): 43.94987346788065
Revenue growth (%): 4.780104954807272
Rule of 40 score: 48.72997842268792
Financial ratios for CIP.AX — annual report dated 2024-06-30
Total revenue: 147430666.66666666
Gross profit: 132036000
Operating income: 95725333.33333333
Net income: 32099333.333333332
Capital expenditures: 0
Net tangible assets: 1638473333.3333333
Owner earnings: 32099333.333333332
Return on net tangible assets (%): 1.9591001379332795
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8066666666666666
P/E ratio: 35.14281667324347
Shares outstanding: 624388000
Book value: 1638473333.3333335
P/B ratio: 0.6884829699191524
Market cap (USD): 1128060986.6666667
Debt to equity: 0.5431389382799434
Current ratio: 1.7139670668503575
Quick ratio: 1.7139670668503575
Effective tax rate (%): 0
Interest coverage ratio: 2.794519481530497
COGS to revenue (%): 10.441970462952078
Free cash flow (dilution-adjusted): 63695333.333333336
Buyback yield (%): 0
Retained earnings: 411481333.3333333
Receivables turnover: 11.347803776683087
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.756441881339362
FCF margin (%): 43.20358496197083
Revenue growth (%): 0.24419648351779832
Rule of 40 score: 43.44778144548863
Financial ratios for CTL.L — annual report dated 2022-12-31
Total revenue: 0
Operating income: -4570826.506024096
Net income: -4578960.240963856
Capital expenditures: 5305093.975903614
Operating cash flow: -4170555.421686747
Net tangible assets: 20879843.373493977
Owner earnings: -9884054.21686747
Return on net tangible assets (%): -47.33777950372382
Buffett classification: The Gruesome
Stock price: 0.009397590361445784
Shares outstanding: 362991716
Book value: 20879843.373493977
P/B ratio: 0.16337514561515776
Market cap (USD): 3411247.4515662654
Debt to equity: 0
Current ratio: 19.955319639098313
Quick ratio: 19.955319639098313
Interest coverage ratio: -561.9591171678269
Free cash flow (dilution-adjusted): -9480516.867469879
Buyback yield (%): 0
Retained earnings: -6702027.710843374
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.8910957532687
Rule of 40 score: 0
Financial ratios for CTL.L — annual report dated 2023-12-31
Total revenue: 0
Operating income: -6884554.4303797465
Net income: -7450126.582278481
Capital expenditures: 11204663.29113924
Operating cash flow: -6846300
Net tangible assets: 25054416.455696203
Owner earnings: -18654789.87341772
Return on net tangible assets (%): -74.45709185206944
Buffett classification: The Gruesome
Stock price: 0.005063291139240506
Shares outstanding: 362991716
Book value: 25054416.4556962
P/B ratio: 0.07335763506967038
Market cap (USD): 1837932.7392405064
Debt to equity: 0
Current ratio: 9.328302868487711
Quick ratio: 9.328302868487711
Free cash flow (dilution-adjusted): -18050963.29113924
Buyback yield (%): 0
Retained earnings: -14491497.46835443
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.478406621657804
Rule of 40 score: 0
Financial ratios for CTL.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: -6383017.5
Net income: -9052773.75
Capital expenditures: 8128068.75
Operating cash flow: -4342800
Net tangible assets: 17437796.25
Owner earnings: -17180842.5
Return on net tangible assets (%): -98.52645514194491
Buffett classification: The Gruesome
Stock price: 0.002125
Shares outstanding: 362991716
Book value: 17437796.25
P/B ratio: 0.04423479810414691
Market cap (USD): 771357.3965
Debt to equity: 0.1566378406331018
Current ratio: 0.05783449759140262
Quick ratio: 0.05783449759140262
Interest coverage ratio: -3.9201644093898214
Free cash flow (dilution-adjusted): -12470868.75
Buyback yield (%): 0
Retained earnings: -23363126.25
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.391247801179716
Rule of 40 score: 0
Financial ratios for CTL.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 17437796.25
Buffett classification: The Gruesome
Stock price: 0.002125
Shares outstanding: 362991716
Book value: 17437796.25
P/B ratio: 0.04423479810414691
Market cap (USD): 771357.3965
Debt to equity: 0.1566378406331018
Current ratio: 0.05783449759140262
Quick ratio: 0.05783449759140262
Buyback yield (%): 0
Retained earnings: -23363126.25
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDP.LS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.329545454545454
Shares outstanding: 4133921624
Market cap (USD): 17898001576.63636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDP.LS — annual report dated 2022-12-31
Total revenue: 21968897872.340427
Gross profit: 5337641489.361702
Operating income: 1700830851.06383
Net income: 1244413829.787234
Capital expenditures: 3652918085.1063833
Operating cash flow: 4018920212.765958
Depreciation & amortization: 2127562765.9574468
Net tangible assets: 457679787.2340426
Owner earnings: -280941489.36170244
Return on net tangible assets (%): -61.38385333981072
Capex to operating income (%): 214.77256734974958
Buffett classification: The Gruesome
Stock price: 4.0638297872340425
P/E ratio: 13.499973587222557
Shares outstanding: 4133921624
Book value: 14717668085.106377
P/B ratio: 1.1414548647623413
Market cap (USD): 16799553833.702127
Debt to equity: 1.5982089264834978
Current ratio: 0.881615753468918
Quick ratio: 0.8095177208046009
Effective tax rate (%): 24.601595408739374
Interest coverage ratio: 1.5046302657509032
COGS to revenue (%): 75.70364466903015
Free cash flow (dilution-adjusted): 295520212.7659575
Buyback yield (%): 0
Retained earnings: 722341489.3617022
Inventory turnover: 12.443987104990846
Receivables turnover: 12.85707508316321
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8625805644996167
FCF margin (%): 1.3451754133648517
Rule of 40 score: 1.3451754133648517
Financial ratios for EDP.LS — annual report dated 2023-12-31
Total revenue: 18002564444.444443
Gross profit: 6467828888.888888
Operating income: 2493763333.3333335
Net income: 1479322222.222222
Capital expenditures: 5935223333.333333
Operating cash flow: 2428570000
Depreciation & amortization: 2287747777.7777777
Net tangible assets: 3721181111.111111
Owner earnings: -2168153333.333333
Return on net tangible assets (%): -58.26519238366073
Capex to operating income (%): 238.00267066241244
Buffett classification: The Gruesome
Stock price: 4.311111111111111
P/E ratio: 12.047270823064618
Shares outstanding: 4133921624
Book value: 18507558888.888885
P/B ratio: 0.9629468452691674
Market cap (USD): 17821795445.68889
Debt to equity: 1.3589461915350747
Current ratio: 0.9065723631062164
Quick ratio: 0.846390594211358
Effective tax rate (%): 26.865783109301294
Interest coverage ratio: 1.9093203685271676
COGS to revenue (%): 64.07273581023148
Free cash flow (dilution-adjusted): -3577670000
Buyback yield (%): 0
Retained earnings: 1058164444.4444444
Inventory turnover: 12.88880473972249
Receivables turnover: 11.405232848304557
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.181775780188001
FCF margin (%): -19.8731131391898
Revenue growth (%): -18.054312287052554
Rule of 40 score: -37.92742542624235
Financial ratios for EDP.LS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.1
Shares outstanding: 4133921624
Market cap (USD): 16949078658.399998
Buyback yield (%): 0.08990983637530328
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDP.LS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.895833333333333
Shares outstanding: 4133921624
Market cap (USD): 11971148036.166666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDP.LS — annual report dated 2024-12-31
Total revenue: 15589335416.666668
Gross profit: 5996528125
Operating income: 1810778125
Net income: 859781250
Capital expenditures: 5514143750
Operating cash flow: 4372795833.333334
Depreciation & amortization: 2484581250
Net tangible assets: 3617660416.666667
Owner earnings: -2169781250
Return on net tangible assets (%): -59.97747162789947
Capex to operating income (%): 304.5179127067266
Buffett classification: The Gruesome
Stock price: 2.895833333333333
P/E ratio: 13.9234811600819
Shares outstanding: 4133921624
Book value: 16880545833.333328
P/B ratio: 0.7091683026343689
Market cap (USD): 11971148036.166666
Debt to equity: 1.4562958445014742
Current ratio: 1.091044827424006
Quick ratio: 1.0376812328355725
Effective tax rate (%): 36.70587672427479
Interest coverage ratio: 1.588011535907201
COGS to revenue (%): 61.53442103382374
Free cash flow (dilution-adjusted): -1365214583.3333335
Buyback yield (%): 0
Retained earnings: 834354166.6666667
Inventory turnover: 15.610593532070126
Receivables turnover: 14.081751863278939
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8309853654718085
FCF margin (%): -8.757362304705902
Revenue growth (%): -13.40491814499513
Rule of 40 score: -22.16228044970103
Financial ratios for EDP.LS — quarterly report dated 2025-03-31
Total revenue: 4442125000
Gross profit: 1913347826.0869565
Operating income: 827901086.9565217
Net income: 527389130.43478256
Capital expenditures: 1363295652.173913
Operating cash flow: 916380434.7826086
Depreciation & amortization: 522514130.43478256
Net tangible assets: 4150409782.6086955
Owner earnings: -313392391.3043479
Return on net tangible assets (%): -7.5508782920073125
Capex to operating income (%): 164.66890473420867
Buffett classification: The Gruesome
Stock price: 3.043478260869565
P/E ratio: 5.964050010098971
Shares outstanding: 4133921624
Book value: 18056300000
P/B ratio: 0.6967928420984701
Market cap (USD): 12581500594.782608
Debt to equity: 1.425734339622278
Current ratio: 1.0693094846096043
Quick ratio: 1.0162487889032263
Effective tax rate (%): 25.294084435473625
Interest coverage ratio: 2.439143815108128
COGS to revenue (%): 56.92719529308706
Free cash flow (dilution-adjusted): -473204347.82608694
Buyback yield (%): 0
Retained earnings: 465284782.6086956
Inventory turnover: 3.906654061351836
Receivables turnover: 3.1537667276570365
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6787508069274908
FCF margin (%): -10.652657181553579
Rule of 40 score: -10.652657181553579
Financial ratios for EDP.LS — quarterly report dated 2025-06-30
Total revenue: 4197689411.764706
Gross profit: 1614361176.4705882
Operating income: 790774117.6470588
Net income: 395721176.47058827
Capital expenditures: 977343529.4117647
Operating cash flow: 573817647.0588236
Depreciation & amortization: 569814117.6470588
Net tangible assets: 3435572941.1764708
Owner earnings: -11808235.29411757
Return on net tangible assets (%): -0.34370498010948886
Capex to operating income (%): 123.5932622984477
Buffett classification: The Gruesome
Stock price: 4.141176470588236
P/E ratio: 18.54523650370164
Shares outstanding: 4133921624
Book value: 17930676470.588234
P/B ratio: 0.9547491969221332
Market cap (USD): 17119298960.564707
Debt to equity: 1.5608292066012406
Current ratio: 0.9815570264857768
Quick ratio: 0.9308774210183494
Effective tax rate (%): 23.130658998278726
Interest coverage ratio: 1.2489510905313856
COGS to revenue (%): 61.541671664747774
Free cash flow (dilution-adjusted): -417545882.3529412
Buyback yield (%): 0
Retained earnings: 834088235.2941177
Inventory turnover: 3.9532148476741553
Receivables turnover: 3.268905037800914
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5750833520018073
FCF margin (%): -9.94704089308516
Revenue growth (%): -5.502672442475029
Rule of 40 score: -15.44971333556019
Financial ratios for EDP.LS — quarterly report dated 2025-09-30
Total revenue: 4457307058.823529
Gross profit: 1551941176.4705882
Operating income: 707647058.8235295
Net income: 309222352.9411765
Capital expenditures: 1121700000
Operating cash flow: 935914117.6470588
Depreciation & amortization: 616424705.882353
Net tangible assets: 2837389411.764706
Owner earnings: -196052941.17647052
Return on net tangible assets (%): -6.909624049613125
Capex to operating income (%): 158.51122194513715
Buffett classification: The Gruesome
Stock price: 4.541176470588235
P/E ratio: 15.233603897589099
Shares outstanding: 4133921624
Book value: 18319644705.882355
P/B ratio: 1.0247397212969322
Market cap (USD): 18772867610.164707
Debt to equity: 1.4973685592926345
Current ratio: 0.8963489612962747
Quick ratio: 0.8426152376936435
Effective tax rate (%): 32.85860600782075
Interest coverage ratio: 1.534618858335417
COGS to revenue (%): 65.18208963417901
Free cash flow (dilution-adjusted): -199640000
Buyback yield (%): 0.09427247571511668
Retained earnings: 1120258823.5294118
Inventory turnover: 4.540727638457055
Receivables turnover: 3.9161867964099395
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4002658060677253
FCF margin (%): -4.478937559502427
Revenue growth (%): 6.184775041507418
Rule of 40 score: 1.7058374820049913
Financial ratios for EDP.LS — annual report dated 2025-12-31
Total revenue: 18361168235.294117
Gross profit: 6896072941.176471
Operating income: 2874538823.529412
Net income: 1591415294.1176472
Capital expenditures: 4725509411.764706
Operating cash flow: 3845260000
Depreciation & amortization: 2309091764.7058825
Net tangible assets: 3130885882.352941
Owner earnings: -825002352.9411759
Return on net tangible assets (%): -26.350444696539547
Capex to operating income (%): 164.39191473373938
Buffett classification: The Gruesome
Stock price: 4.4
P/E ratio: 11.429609362705635
Shares outstanding: 4133921624
Book value: 19419092941.176468
P/B ratio: 0.9366686281742489
Market cap (USD): 18189255145.600002
Debt to equity: 1.431821465702433
Current ratio: 1.1530693048986247
Quick ratio: 1.0992354637415562
Effective tax rate (%): 28.933095993853993
Interest coverage ratio: 1.9512272643058384
COGS to revenue (%): 62.44207964980827
Free cash flow (dilution-adjusted): -1181487058.8235295
Buyback yield (%): 0
Retained earnings: 1352618823.5294118
Inventory turnover: 19.350832881597576
Receivables turnover: 16.41612750878027
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.358074023260196
FCF margin (%): -6.434705263211178
Revenue growth (%): 17.78031419905215
Rule of 40 score: 11.345608935840971
Financial ratios for EDP.LS — quarterly report dated 2025-12-31
Total revenue: 4898224705.882353
Gross profit: 1658852941.1764705
Operating income: 739129411.7647059
Net income: 315650588.2352941
Capital expenditures: 1150898823.5294118
Operating cash flow: 1343681176.4705882
Depreciation & amortization: 557308235.2941177
Net tangible assets: 3130885882.352941
Owner earnings: -277940000
Return on net tangible assets (%): -8.877359649758967
Capex to operating income (%): 155.71005634609875
Buffett classification: The Gruesome
Stock price: 4.4
P/E ratio: 11.750291980316275
Shares outstanding: 4133921624
Book value: 19419092941.176468
P/B ratio: 0.9366686281742489
Market cap (USD): 18189255145.600002
Debt to equity: 1.431821465702433
Current ratio: 1.1530693048986247
Quick ratio: 1.0992354637415562
Effective tax rate (%): 37.27043412842412
Interest coverage ratio: 2.037483257716044
COGS to revenue (%): 66.13358837571644
Free cash flow (dilution-adjusted): -52127058.823529415
Buyback yield (%): 0
Retained earnings: 1352618823.5294118
Inventory turnover: 5.467424391348119
Receivables turnover: 4.379344511633925
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3777201645659174
FCF margin (%): -1.0642030930293833
Revenue growth (%): 9.892018683927068
Rule of 40 score: 8.827815590897686
Financial ratios for ELV.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.796992481203006
Shares outstanding: 169329111
Market cap (USD): 1658916027.3157892
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELV.AX — annual report dated 2022-06-30
Operating income: -9822811.641379312
Net income: 39702411.386206895
Capital expenditures: 65719768.99310345
Depreciation & amortization: 23753.744827586208
Net tangible assets: 242473551.5448276
Owner earnings: -25993603.862068973
Return on net tangible assets (%): -10.720181106953998
Buffett classification: The Gruesome
Stock price: 15.517241379310345
P/E ratio: 66.1803803897883
Shares outstanding: 169329111
Book value: 270797091.8965518
P/B ratio: 9.702913238576372
Market cap (USD): 2627520687.9310346
Debt to equity: 0.041121134002805995
Current ratio: 28.657795445267595
Quick ratio: 28.657795445267595
Effective tax rate (%): 0
Interest coverage ratio: -22.30955771975215
Free cash flow (dilution-adjusted): -75423556.66896552
Buyback yield (%): 0.40887670454307695
Retained earnings: -3492122.724137931
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.166340091890787
Rule of 40 score: 0
Financial ratios for ELV.AX — annual report dated 2023-06-30
Total revenue: 0
Gross profit: 15933703.033112582
Operating income: -9434060.278145695
Net income: -4536642.8013245035
Capital expenditures: 55683356.09933774
Operating cash flow: -20216093.940397352
Depreciation & amortization: 2701207.1655629138
Net tangible assets: 331473013.1589404
Owner earnings: -57518791.73509933
Return on net tangible assets (%): -17.352481032149434
Buffett classification: The Gruesome
Stock price: 17.3841059602649
Shares outstanding: 169329111
Book value: 387875726.7549669
P/B ratio: 7.589119413087281
Market cap (USD): 2943635207.781457
Debt to equity: 0.03527711192014116
Current ratio: 9.74252795185638
Quick ratio: 8.235295939207406
Interest coverage ratio: -16.242264244282737
Free cash flow (dilution-adjusted): -77803709.03311257
Buyback yield (%): 0.22405508063553006
Retained earnings: -11974387.364238411
Inventory turnover: -0.746917639550213
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.202118929870699
Rule of 40 score: 0
Financial ratios for ELV.AX — annual report dated 2024-06-30
Total revenue: 113448431.82
Gross profit: 79446030.04
Operating income: -41067835.92
Net income: -45182952.23333333
Capital expenditures: 45650832.26666667
Operating cash flow: -27706518.906666666
Depreciation & amortization: 15051032.346666666
Net tangible assets: 296342737.71999997
Owner earnings: -75782752.15333334
Return on net tangible assets (%): -25.5726705963474
Buffett classification: The Gruesome
Stock price: 3.6
Shares outstanding: 169329111
Book value: 354534091.7466666
P/B ratio: 1.7193968472729575
Market cap (USD): 609584799.6
Debt to equity: 0.05757791368599818
Current ratio: 2.4627402622768253
Quick ratio: 1.636430486618072
Interest coverage ratio: -27.793425793984024
COGS to revenue (%): 8.87009666438831
SG&A to revenue (%): 20.93465359164157
Free cash flow (dilution-adjusted): -73251743.96666667
Buyback yield (%): 0.1324398728221394
Retained earnings: -52910548.02
Inventory turnover: 0.30918674704770543
Receivables turnover: 8.296845466350533
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.758498481515897
FCF margin (%): -64.56831777356751
Rule of 40 score: -64.56831777356751
Financial ratios for ELV.AX — annual report dated 2025-06-30
Total revenue: 98262281.93464053
Gross profit: 62748854.941176474
Operating income: -48034594.267973855
Net income: -125638593.83006535
Capital expenditures: 7728978.568627452
Operating cash flow: -6314589.150326798
Depreciation & amortization: 16477871.509803921
Net tangible assets: 179400333.89542484
Owner earnings: -116889700.88888888
Return on net tangible assets (%): -65.15578781309607
Buffett classification: The Gruesome
Stock price: 1.4705882352941175
Shares outstanding: 169329111
Book value: 202977902.3529412
P/B ratio: 1.2268005316974029
Market cap (USD): 249013398.52941173
Debt to equity: 0.24971648399656793
Current ratio: 1.3761879039834837
Quick ratio: 0.9768073864151373
Interest coverage ratio: -25.199104155263694
COGS to revenue (%): 33.1870614577379
SG&A to revenue (%): 20.832880758621148
Free cash flow (dilution-adjusted): -15839624.549019609
Buyback yield (%): 0.539383528289671
Retained earnings: -176203122.2026144
Inventory turnover: 1.6141882038902626
Receivables turnover: 6.600091761998834
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.0610450980025
FCF margin (%): -16.119740186326414
Revenue growth (%): -13.385949582321398
Rule of 40 score: -29.505689768647812
Financial ratios for ELV.AX — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 179400333.89542484
Buffett classification: The Gruesome
Stock price: 1.4705882352941175
Shares outstanding: 169329111
Book value: 202977902.3529412
P/B ratio: 1.2268005316974029
Market cap (USD): 249013398.52941173
Debt to equity: 0.24971648399656793
Current ratio: 1.3761879039834837
Quick ratio: 0.9768073864151373
Buyback yield (%): 0
Retained earnings: -176203122.2026144
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELVA.TO — annual report dated 2021-09-30
Capital expenditures: 0
Depreciation & amortization: 249218.75
Buffett classification: The Gruesome
Stock price: 5.0390625
Shares outstanding: 49507480
Market cap (USD): 249471285.9375
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELVA.TO — annual report dated 2022-09-30
Total revenue: 11401459.854014598
Gross profit: 2353284.6715328465
Operating income: -5305839.416058394
Net income: -6723357.6642335765
Capital expenditures: 148175.1824817518
Operating cash flow: -6441605.839416058
Depreciation & amortization: 367153.2846715328
Net tangible assets: -4895620.437956204
Owner earnings: -6504379.562043795
Buffett classification: The Gruesome
Stock price: 3.576642335766423
Shares outstanding: 49507480
Book value: -4895620.4379562065
Market cap (USD): 177070548.9051095
Debt to equity: -3.4455046965856546
Current ratio: 0.6525461124349131
Quick ratio: 0.3279939987644515
Interest coverage ratio: -3.1728502837189003
COGS to revenue (%): 79.35979513444302
R&D to revenue (%): 21.98463508322663
SG&A to revenue (%): 47.4775928297055
Free cash flow (dilution-adjusted): -8942335.766423356
Buyback yield (%): 0
Retained earnings: -94139416.05839415
Inventory turnover: 1.6853840924541128
Receivables turnover: 5.362169584620666
Capitalized R&D asset: 2506569.343065693
ROCI (R&D-adjusted, %): -168.17516604750656
FCF margin (%): -78.43149807938539
Rule of 40 score: -78.43149807938539
Financial ratios for ELVA.TO — annual report dated 2023-09-30
Total revenue: 32122962.962962963
Gross profit: 8268888.888888888
Operating income: 891111.111111111
Net income: -1095555.5555555555
Capital expenditures: 374074.07407407404
Operating cash flow: -3877777.7777777775
Depreciation & amortization: 671851.8518518518
Net tangible assets: 5293333.333333333
Owner earnings: -797777.7777777778
Return on net tangible assets (%): -15.071368597816962
Capex to operating income (%): 41.97838736492103
Buffett classification: The Good
Stock price: 2.7777777777777777
Shares outstanding: 49507480
Book value: 5293333.333333336
P/B ratio: 25.979995801847174
Market cap (USD): 137520777.77777776
Debt to equity: 2.663168205989363
Current ratio: 0.9735071962722182
Quick ratio: 0.6628837698696027
Interest coverage ratio: 0.4813925570228091
COGS to revenue (%): 74.25863579762947
R&D to revenue (%): 7.798736337222708
SG&A to revenue (%): 15.567495272794355
Free cash flow (dilution-adjusted): -5116296.296296296
Buyback yield (%): 0
Retained earnings: -94636296.29629628
Inventory turnover: 3.895838374062424
Receivables turnover: 4.086890962209029
Capitalized R&D asset: 4184586.6450392
ROCI (R&D-adjusted, %): 14.979949235842843
Rosenberg metric: 2.3600401216592246
FCF margin (%): -15.927224092607108
Revenue growth (%): 181.7442974344383
Rule of 40 score: 165.8170733418312
Financial ratios for ELVA.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.3407407407407406
Shares outstanding: 49507480
Market cap (USD): 115884175.4074074
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELVA.TO — annual report dated 2024-09-30
Total revenue: 33028888.888888888
Gross profit: 10120740.74074074
Operating income: 540000
Net income: -1100000
Capital expenditures: 493333.3333333333
Operating cash flow: 768888.8888888889
Depreciation & amortization: 895555.5555555555
Net tangible assets: 6359259.259259258
Owner earnings: -697777.7777777778
Return on net tangible assets (%): -10.97262667443215
Capex to operating income (%): 91.35802469135803
Buffett classification: The Gruesome
Stock price: 2.3407407407407406
Shares outstanding: 49507480
Book value: 6359259.259259261
P/B ratio: 18.22290469423412
Market cap (USD): 115884175.4074074
Debt to equity: 2.419801980198019
Current ratio: 1.0310889909221548
Quick ratio: 0.6911780168939049
Interest coverage ratio: 0.2278125
COGS to revenue (%): 69.35791338670973
R&D to revenue (%): 6.813339612909014
SG&A to revenue (%): 20.24938886272399
Free cash flow (dilution-adjusted): -1320740.7407407407
Buyback yield (%): 0
Retained earnings: -95736296.29629628
Inventory turnover: 3.188904928851309
Receivables turnover: 3.9487247608926674
Capitalized R&D asset: 4756012.327656123
ROCI (R&D-adjusted, %): 2.872753905956199
Rosenberg metric: 0.7392075694855118
FCF margin (%): -3.9987440848639797
Revenue growth (%): 2.820181709173083
Rule of 40 score: -1.1785623756908965
Financial ratios for ELVA.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.4615384615384617
Shares outstanding: 49507480
Market cap (USD): 121864566.15384616
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELVA.TO — quarterly report dated 2025-03-31
Total revenue: 10502097.902097903
Gross profit: 3267832.167832168
Operating income: 976223.7762237763
Net income: 579020.979020979
Capital expenditures: 614685.3146853147
Operating cash flow: -3129370.6293706293
Depreciation & amortization: 229370.62937062938
Net tangible assets: 14776223.776223777
Owner earnings: 193706.29370629368
Return on net tangible assets (%): 1.310932323710364
Capex to operating income (%): 62.965616045845266
Buffett classification: The Good
Stock price: 2.342657342657343
P/E ratio: 50.07550060386474
Shares outstanding: 49507480
Book value: 14776223.776223775
P/B ratio: 7.849032560340749
Market cap (USD): 115979061.53846155
Debt to equity: 0.7135352579271179
Current ratio: 3.893030436700485
Quick ratio: 3.013012792236436
Effective tax rate (%): 0
Interest coverage ratio: 2.174454828660436
COGS to revenue (%): 68.8840058596351
R&D to revenue (%): 7.124783593021706
SG&A to revenue (%): 12.638167532294577
Free cash flow (dilution-adjusted): -3945454.5454545454
Buyback yield (%): 0
Retained earnings: -90095104.8951049
Inventory turnover: 1.2963659147869675
Receivables turnover: 0.8309633154429259
Capitalized R&D asset: 748251.7482517483
ROCI (R&D-adjusted, %): 5.636161211311513
FCF margin (%): -37.56825143161539
Rule of 40 score: -37.56825143161539
Financial ratios for ELVA.TO — quarterly report dated 2025-06-30
Total revenue: 12505839.416058393
Gross profit: 3851824.8175182478
Operating income: 1432116.7883211677
Net income: 662043.795620438
Capital expenditures: 1113138.6861313868
Operating cash flow: -1870072.9927007298
Depreciation & amortization: 283211.67883211677
Net tangible assets: 16302189.781021897
Owner earnings: -167883.21167883207
Return on net tangible assets (%): -1.0298200053729738
Capex to operating income (%): 77.72680937818554
Buffett classification: The Gruesome
Stock price: 3.394160583941606
P/E ratio: 135.39691131337477
Shares outstanding: 49507480
Book value: 16302189.781021897
P/B ratio: 10.307592997223963
Market cap (USD): 168036337.22627738
Debt to equity: 0.9319871048625414
Current ratio: 4.030981887511916
Quick ratio: 2.8779790276453765
Interest coverage ratio: 4.340707964601769
COGS to revenue (%): 69.19978987918053
R&D to revenue (%): 6.823089943384113
SG&A to revenue (%): 10.266736706939824
Free cash flow (dilution-adjusted): -3379562.04379562
Buyback yield (%): 0
Retained earnings: -93378832.11678831
Inventory turnover: 0.98023976849938
Receivables turnover: 0.8969217882944194
Capitalized R&D asset: 1354613.342861518
ROCI (R&D-adjusted, %): 5.304598525700223
Rosenberg metric: 0.7804761579916769
FCF margin (%): -27.0238720597677
Revenue growth (%): 19.07944043789786
Rule of 40 score: -7.9444316218698425
Financial ratios for ELVA.TO — quarterly report dated 2025-09-30
Total revenue: 14769064.74820144
Gross profit: 4397122.302158274
Operating income: 1706474.820143885
Net income: 1473381.294964029
Capital expenditures: 6334532.37410072
Operating cash flow: 6497122.302158274
Depreciation & amortization: 355395.68345323746
Net tangible assets: 22393525.179856118
Owner earnings: -4505755.395683453
Return on net tangible assets (%): -20.12079545089472
Capex to operating income (%): 371.20573355817874
Buffett classification: The Gruesome
Stock price: 5.899280575539568
P/E ratio: 107.59414908927086
Shares outstanding: 49507480
Book value: 22393525.17985612
P/B ratio: 13.042096443602013
Market cap (USD): 292058515.1079137
Debt to equity: 0.7247405789186235
Current ratio: 4.163127604683469
Quick ratio: 2.9276642190910893
Interest coverage ratio: 2.875151515151515
COGS to revenue (%): 69.25325149788104
R&D to revenue (%): 5.63105850260607
SG&A to revenue (%): 11.417994057187395
Free cash flow (dilution-adjusted): -204316.54676258992
Buyback yield (%): 0
Retained earnings: -90561870.50359713
Inventory turnover: 1.141835997108666
Receivables turnover: 1.2461454413014446
Capitalized R&D asset: 1650278.483109077
ROCI (R&D-adjusted, %): 4.275609180113639
Rosenberg metric: 0.6390569323839485
FCF margin (%): -1.3834088362803838
Revenue growth (%): 18.097348421385473
Rule of 40 score: 16.713939585105088
Financial ratios for ELVA.TO — annual report dated 2025-09-30
Total revenue: 45738129.49640288
Gross profit: 14007194.244604317
Operating income: 3985611.5107913674
Net income: 2419424.460431655
Capital expenditures: 8071223.021582735
Operating cash flow: 1235251.7985611511
Depreciation & amortization: 1098561.1510791369
Net tangible assets: 22393525.179856118
Owner earnings: -4553237.410071943
Return on net tangible assets (%): -20.332830018954606
Capex to operating income (%): 202.50902527075812
Buffett classification: The Gruesome
Stock price: 5.899280575539568
P/E ratio: 120.7140457924472
Shares outstanding: 49507480
Book value: 22393525.17985612
P/B ratio: 13.042096443602013
Market cap (USD): 292058515.1079137
Debt to equity: 0.7247405789186235
Current ratio: 4.163127604683469
Quick ratio: 2.9276642190910893
Effective tax rate (%): -156.7175572519084
Interest coverage ratio: 2.1274961597542243
COGS to revenue (%): 69.49005914181453
R&D to revenue (%): 6.887819302881591
SG&A to revenue (%): 13.154334969170755
Free cash flow (dilution-adjusted): -8099280.575539569
Buyback yield (%): 0
Retained earnings: -90561870.50359713
Inventory turnover: 3.5482290579069957
Receivables turnover: 3.859172028651208
Capitalized R&D asset: 5484818.971489475
ROCI (R&D-adjusted, %): 10.176059774904092
Rosenberg metric: 1.727028383876178
FCF margin (%): -17.707940103183592
Revenue growth (%): 38.479164861611366
Rule of 40 score: 20.771224758427774
Financial ratios for ELVA.TO — quarterly report dated 2025-12-31
Total revenue: 11353284.671532845
Gross profit: 3732846.715328467
Operating income: 1000729.9270072991
Net income: 757664.2335766422
Capital expenditures: 11627737.226277372
Operating cash flow: 1244525.5474452553
Depreciation & amortization: 302189.7810218978
Net tangible assets: 44029197.080291964
Owner earnings: -10567883.211678833
Return on net tangible assets (%): -24.001989389920432
Capex to operating income (%): 1161.925601750547
Buffett classification: The Gruesome
Stock price: 7.912408759124087
P/E ratio: 112.81998098826452
Shares outstanding: 49507480
Book value: 44029197.08029196
P/B ratio: 8.896901246684353
Market cap (USD): 391723418.39416057
Debt to equity: 0.4804210875331566
Current ratio: 6.019344230583228
Quick ratio: 4.688074281845439
Effective tax rate (%): -10.543130990415337
Interest coverage ratio: 2.8385093167701863
COGS to revenue (%): 67.12099781406712
R&D to revenue (%): 7.86935836440787
SG&A to revenue (%): 14.735759290214737
Free cash flow (dilution-adjusted): -10525547.445255473
Buyback yield (%): 0
Retained earnings: -91126277.37226276
Inventory turnover: 0.7585004359197908
Receivables turnover: 1.113864222285878
Capitalized R&D asset: 1732223.231633671
ROCI (R&D-adjusted, %): 1.5413092496011116
Rosenberg metric: -0.7987396762053903
FCF margin (%): -92.70927092709272
Revenue growth (%): -23.12793758375637
Rule of 40 score: -115.83720851084908
Financial ratios for EMMN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1080.4835164835165
Shares outstanding: 5349810
Market cap (USD): 5780381521.318682
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMMN.SW — annual report dated 2022-12-31
Total revenue: 4597835869.565217
Gross profit: 1612103260.8695652
Operating income: 290316304.34782606
Net income: 207178260.86956522
Capital expenditures: 215513043.47826087
Operating cash flow: 226465217.39130434
Depreciation & amortization: 120948913.04347825
Net tangible assets: 1136711956.521739
Owner earnings: 112614130.43478262
Return on net tangible assets (%): 9.90700676531759
Capex to operating income (%): 74.23387534585592
Buffett classification: The Good
Stock price: 788.3043478260869
P/E ratio: 20.355796333760047
Shares outstanding: 5349810
Book value: 1395550000
P/B ratio: 3.021947248786126
Market cap (USD): 4217278483.043478
Debt to equity: 0.5404718102415597
Current ratio: 1.653090452077716
Quick ratio: 1.0341475652201446
Effective tax rate (%): 16.964429632533925
Interest coverage ratio: 16.459665988784128
COGS to revenue (%): 64.93778145625694
SG&A to revenue (%): 4.591337748926776
Free cash flow (dilution-adjusted): 4105434.7826086953
Buyback yield (%): 0
Retained earnings: 1346948913.0434783
Inventory turnover: 5.404678891862113
Receivables turnover: 7.927540930762541
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.721459606668589
FCF margin (%): 0.0892905901618649
Rule of 40 score: 0.0892905901618649
Financial ratios for EMMN.SW — annual report dated 2023-12-31
Total revenue: 5050484523.809524
Gross profit: 1851382142.857143
Operating income: 309717857.14285713
Net income: 244621428.57142857
Capital expenditures: 173614285.71428573
Operating cash flow: 440648809.52380955
Depreciation & amortization: 136530952.3809524
Net tangible assets: 1413467857.1428573
Owner earnings: 207538095.23809522
Return on net tangible assets (%): 14.682901644301035
Capex to operating income (%): 56.05562666482168
Buffett classification: The Good
Stock price: 1020.1904761904763
P/E ratio: 22.311312804041233
Shares outstanding: 5349810
Book value: 1684385714.2857141
P/B ratio: 3.2402466757698867
Market cap (USD): 5457825211.428572
Debt to equity: 0.48222822507004115
Current ratio: 2.3521465268948343
Quick ratio: 1.5715881963725062
Effective tax rate (%): 13.701823129937383
Interest coverage ratio: 13.7021646389635
COGS to revenue (%): 63.342484584812354
SG&A to revenue (%): 4.877985539812658
Free cash flow (dilution-adjusted): 262178571.42857143
Buyback yield (%): 0
Retained earnings: 1641653571.4285715
Inventory turnover: 5.583180106002149
Receivables turnover: 8.95655579365163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.401215892402009
FCF margin (%): 5.191156812630189
Revenue growth (%): 9.844819760543349
Rule of 40 score: 15.035976573173539
Financial ratios for EMMN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 596444444.4444444
Buffett classification: The Gruesome
Stock price: 783.5555555555555
Shares outstanding: 5349810
Book value: 1255334444.4444442
P/B ratio: 3.3392482499130387
Market cap (USD): 4191873346.6666665
Debt to equity: 1.1774905492206151
Current ratio: 1.9810802395881983
Quick ratio: 1.263567434584102
Buyback yield (%): 0
Retained earnings: 2659202222.2222223
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMMN.SW — annual report dated 2024-12-31
Total revenue: 4832013333.333333
Gross profit: 1849926666.6666665
Operating income: 337717777.7777778
Net income: 264581111.1111111
Capital expenditures: 125431111.1111111
Operating cash flow: 452085555.5555555
Depreciation & amortization: 139700000
Net tangible assets: 596444444.4444444
Owner earnings: 278850000
Return on net tangible assets (%): 46.75204918032787
Capex to operating income (%): 37.140807906667625
Buffett classification: The Good
Stock price: 783.5555555555555
P/E ratio: 15.84343390600656
Shares outstanding: 5349810
Book value: 1255334444.4444442
P/B ratio: 3.3392482499130387
Market cap (USD): 4191873346.6666665
Debt to equity: 1.1774905492206151
Current ratio: 1.9810802395881983
Quick ratio: 1.263567434584102
Effective tax rate (%): 15.164826551806446
Interest coverage ratio: 13.800671994188159
COGS to revenue (%): 61.71519946137014
SG&A to revenue (%): 5.11054513278569
Free cash flow (dilution-adjusted): 314440000
Buyback yield (%): 0
Retained earnings: 2659202222.2222223
Inventory turnover: 4.773044234473119
Receivables turnover: 8.056443859034852
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.79983764576262
FCF margin (%): 6.507432374634728
Revenue growth (%): -4.325747152500929
Rule of 40 score: 2.1816852221337992
Financial ratios for EMMN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 658365000
Buffett classification: The Gruesome
Stock price: 970.3
Shares outstanding: 5349810
Book value: 1361217500
P/B ratio: 3.8134395443784697
Market cap (USD): 5190920643
Debt to equity: 1.2102896855204992
Current ratio: 1.9695206174841882
Quick ratio: 1.186407175571371
Buyback yield (%): 0
Retained earnings: 3002807500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FDJU.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33.67045454545455
Shares outstanding: 184577185
Market cap (USD): 6214797717.670455
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FDJU.PA — annual report dated 2022-12-31
Total revenue: 2618191489.3617024
Gross profit: 1203723404.255319
Operating income: 477446808.5106383
Net income: 327553191.4893617
Capital expenditures: 110744680.85106383
Operating cash flow: 432021276.5957447
Depreciation & amortization: 139148936.17021278
Net tangible assets: 384042553.1914894
Owner earnings: 355957446.80851066
Return on net tangible assets (%): 92.68698060941828
Capex to operating income (%): 23.1951871657754
Buffett classification: The Great
Stock price: 31.52127659574468
P/E ratio: 17.76233189850601
Shares outstanding: 184577185
Book value: 984468085.1063833
P/B ratio: 5.909900574400257
Market cap (USD): 5818108501.648936
Debt to equity: 0.5059433758374755
Current ratio: 0.8096308186195825
Quick ratio: 0.7997324772605671
Effective tax rate (%): 26.89933523266857
Interest coverage ratio: 68
COGS to revenue (%): 54.024623135996094
SG&A to revenue (%): 26.85384584129048
Free cash flow (dilution-adjusted): 321276595.7446809
Buyback yield (%): 0
Retained earnings: 869468085.1063831
Inventory turnover: 71.87027027027028
Receivables turnover: 5.283598110777158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.022326674500583
FCF margin (%): 12.270935760432327
Rule of 40 score: 12.270935760432327
Financial ratios for FDJU.PA — annual report dated 2023-12-31
Total revenue: 2912777777.7777777
Gross profit: 1542222222.222222
Operating income: 579222222.2222222
Net income: 472333333.3333333
Capital expenditures: 138444444.44444445
Operating cash flow: 698777777.7777778
Depreciation & amortization: 139555555.55555555
Net tangible assets: -52666666.666666664
Owner earnings: 473444444.4444444
Return on net tangible assets (%): -898.9451476793249
Capex to operating income (%): 23.901784001534626
Buffett classification: The Great
Stock price: 29.822222222222223
P/E ratio: 11.653850024464832
Shares outstanding: 184577185
Book value: 1190111111.1111112
P/B ratio: 4.625199930351974
Market cap (USD): 5504501828.222222
Debt to equity: 0.4003361030716086
Current ratio: 0.7898264066644949
Quick ratio: 0.7792618792758412
Effective tax rate (%): 24.91166077738516
Interest coverage ratio: 37.775362318840585
COGS to revenue (%): 47.053213808888046
SG&A to revenue (%): 9.658592408926186
Free cash flow (dilution-adjusted): 560222222.2222222
Buyback yield (%): 0
Retained earnings: 1087555555.5555556
Inventory turnover: 54.33920704845816
Receivables turnover: 4.685433422698838
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 32.33670367843185
FCF margin (%): 19.23326339881747
Revenue growth (%): 11.251518065544296
Rule of 40 score: 30.484781464361767
Financial ratios for FDJU.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -2859270833.3333335
Buffett classification: The Gruesome
Stock price: 33.375
Shares outstanding: 184577185
Book value: 1238958333.333334
P/B ratio: 4.972131332940976
Market cap (USD): 6160263549.375
Debt to equity: 1.9619976458718673
Current ratio: 0.7243555650108146
Quick ratio: 0.7172995780590717
Buyback yield (%): 0
Retained earnings: 1156041666.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0